BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19957514)

  • 1. [Expression of FOXP3 in CD4+ CD39+ T cells of patients with systemic lupus erythematosus and dynamic observation of treatment with glucocorticoid].
    Li DM; Li XP; Li XM; Wang GS; Ma Y; Zhao SS; Zheng SG
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1636-8. PubMed ID: 19957514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
    Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
    Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang F; Zhu L; Liu Y
    Clin Exp Immunol; 2008 Aug; 153(2):182-7. PubMed ID: 18505426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of FOXP3
    Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
    Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus].
    Zhao SS; Li XM; Li XP; Zhai ZM; Chen Z; Ma Y; Zhang H; Zheng SG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):453-6. PubMed ID: 18642784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of Foxp3+ CD4+ CD25+ regulatory cells in peripheral blood of patients with SLE].
    Wei HG; Cai B; Wang LL; Li J; Feng WH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):432-5. PubMed ID: 17488604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD4
    Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
    Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients.
    Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH
    Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and significance of Th17 and Treg cells in peripheral blood of patients with systemic lupus erythematosus].
    Cai XY; Luo M; Lin XJ; Xu YL; Tang C; Ye JH; Li WN; He ZX; Yu N
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(7):460-3. PubMed ID: 22490966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Altered frequency of CD4+CD25-Foxp3+ T cells in patients with systemic lupus erythematosus].
    Yan B; Liu Y; Xie QB; Liu G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):695-8. PubMed ID: 19664391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus.
    Suen JL; Li HT; Jong YJ; Chiang BL; Yen JH
    Immunology; 2009 Jun; 127(2):196-205. PubMed ID: 18800986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
    Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus.
    Hu S; Xiao W; Kong F; Ke D; Qin R; Su M
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):549-52. PubMed ID: 18846336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant GITR expression on different T cell subsets and the regulation by glucocorticoid in systemic lupus erythematosus.
    Sun J; Yu N; Li X; Wang L; Pan Y; Li X; Tao J; Chen Z; Wang G
    Int J Rheum Dis; 2016 Feb; 19(2):199-204. PubMed ID: 25293713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The severity of systemic lupus erythematosus negatively correlates with the increasing number of CD4+CD25(high)FoxP3+ regulatory T cells during repeated plasmapheresis treatments of patients.
    Baráth S; Soltész P; Kiss E; Aleksza M; Zeher M; Szegedi G; Sipka S
    Autoimmunity; 2007 Nov; 40(7):521-8. PubMed ID: 17966042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of fas-mediated Foxp3+CD4+CD25+ Treg cell apoptosis in patients with systemic lupus erythematosus].
    Lin XJ; Luo M; Cai XY
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(9):586-90. PubMed ID: 21600126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.